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CONFORMAL CONDUCTIVE SCAFFOLDS AND METHODS OF USING
CONFORMAL CONDUCTIVE SCAFFOLDS
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of and priority to U.S. Provisional Application
Serial No. 62/192,752, having the title "CONFORMAL CONDUCTIVE SCAFFOLDS AND
METHODS OF USING CONFORMAL CONDUCTIVE SCAFFOLDS," filed on July 15,
2015, the disclosure of which is incorporated herein in by reference in its entirety.
BACKGROUND
Cells inhabit environments known as the extracellular matrix (ECM) which consists
of a mixture of different biomolecules, and the precise composition and topographical
properties are different in different tissues (e.g., bone, brain, muscle, skin). Cells interact
intimately with the ECM, not only constructing the biomolecules, but assist its organization
in 3D space, and its degradation (which is important for tissue remodeling); reciprocally,
cells respond to the ECM (e.g., by modifying their size, shape). Cellular alignment is
observed in organs and tissues such as bones, muscles and skin, and this alignment is
important for the healthy functioning of the organ/tissue.
SUMMARY
Embodiments of the present disclosure provide for structures including a conformal
conductive scaffold, methods of making the structure, method of using structure, and the like.
An embodiment of the present disclosure provides for a structure, among others, that
includes a conformal conductive scaffold including a polyelectrolyte complex, chitosan, and
gelatin, which are crosslinked by genipin. In an embodiment, the polyelectrolyte complex
can be a PEDOT derivative, polypyrrole-polystyrenesulfonate (PSS), polyaniline-PSS,
polythiophene-PSS, or a combination thereof.
An embodiment of the present disclosure provides for a method of alignment of cells,
among others, that includes: providing a structure having a conformal conductive scaffold
including a polyelectrolyte complex, chitosan, and gelatin, which are crosslinked by genipin;
introducing cells to the structure; periodically providing electrical stimulation to cells; and
aligning the cells on the structure. In an embodiment, the cell is a human dermal fibroblast or
a human mesenchymal stem cell. In an embodiment, the electrical stimulation can be a direct
current (DC) or an alternating current (AC).
Other compositions, structures, methods, features, and advantages will be or become
apparent to one with skill in the art upon examination of the following drawings and detailed
description. It is intended that all such additional compositions, apparatus, methods, features
and advantages be included within this description, be within the scope of the present
disclosure, and be protected by the accompanying claims.
BRIEF DESCRIPTION OF THE DRAWINGS
Further aspects of the present disclosure will be more readily appreciated upon review
of the detailed description of its various embodiments, described below, when taken in
conjunction with the accompanying drawings.
Figure 1.1 illustrates molecules employed in this study. Abbreviations: (CHI)
Chitosan, (GEN) Genipin. (PSS) Polystyrenesulfonate, (PEDOT) Poly(3,4-
ethylenedioxythiophene), and (PEDOT-S) Sulfonated PEDOT derivative.
Figures 1.2A-E show adhesion and proliferation of human dermal fibroblasts on
various surfaces up to 4 days in culture. Fig. 1.2A illustrates tissue culture plate controls. Fig.
1.2B illustrates PEDOT-PSS-based multilayer films. Fig. 1.2C illustrates PEDOT-S-based
multilayer films. Cells were stained with a LIVE/DEAD® Viability/Cytotoxicity Kit, live
cells were green and dead cells were red. Scale bars represent 250 µ . Fig. 1.2D illustrates
cell viability after 4 days in culture as determined with a LIVE/DEAD®
Viability/Cytotoxicity Kit. Fig. 1.2E illustrates cell adhesion after 2 days (grey bars) or 4
days (black bars) as determined by the AlamarBlue® assay. Error bars represent standard
deviations (n = 3).
Figures 1.3A-F show analysis of the morphology of human dermal fibroblasts on
various surfaces with optional electrical stimulation. Figure 1.3A illustrates PEDOT-PSS-
based multilayer films without electrical stimulation, PEDOT-PSS(-). Figure 1.3B illustrates
PEDOT-PSS-based multilayer films with electrical stimulation, PEDOT-PSS(+). Figure
1.3C illustrates PEDOT-S-based multilayer films without electrical stimulation, PEDOT-S(-).
Figure 1.3D illustrates PEDOT-S-based multilayer films with electrical stimulation PEDOT-
S(+). DAPI-stained nuclei are blue and Alexa Fluor® 488-stained actin is green. Scale bars
represent 200 µ . Figure 1.3E illustrates assessment of cell alignment. Figure 1.3F
illustrates assessment of cell length. Error bars represent standard errors of the mean (n =
150 or more).
Figure 1.4 is an example of an experimental setup for dip coating multilayer films
using a Gilson 223 Sample Changer converted for use as a dip coater.
Figure 1.5 is a schematic of an experimental setup for electrical stimulation of
PEDOT-based films (Not to scale). Abbreviations: (CE) counter electrode, (CT) copper tape,
(PCW) polycarbonate well, (RE) reference electrode, and (WE) working electrode.
Figure 1.6 illustrates cell alignment & length assessment.
Figures 1.7A-B show polar plots for multilayer films. Fig. 1.7A illustrates PEDOT-
PSS-based films. Fig. 1.7B illustrates PEDOT-S-based films. Black circles represent cells
without electrical stimulation, whereas red circles represent cells with electrical stimulation;
black and red lines represent the corresponding trend lines.
Figures 1.8A-B are FDVISCs on multilayer films after 3 days in culture. Fig. 1.8A
illustrates PEDOT-PSS-based multilayer films. Fig. 1.8B illustrates PEDOT-S-based
multilayer films. DAPI-stained nuclei are blue and Alexa Fluor® 488-stained actin is green.
Scale bars represent 150 µ .
DETAILED DESCRIPTION
This disclosure is not limited to particular embodiments described, and as such may,
of course, vary. The terminology used herein serves the purpose of describing particular
embodiments only, and is not intended to be limiting, since the scope of the present
disclosure will be limited only by the appended claims.
Where a range of values is provided, each intervening value, to the tenth of the unit of
the lower limit unless the context clearly dictates otherwise, between the upper and lower
limit of that range and any other stated or intervening value in that stated range, is
encompassed within the disclosure. The upper and lower limits of these smaller ranges may
independently be included in the smaller ranges and are also encompassed within the
disclosure, subject to any specifically excluded limit in the stated range. Where the stated
range includes one or both of the limits, ranges excluding either or both of those included
limits are also included in the disclosure.
As will be apparent to those of skill in the art upon reading this disclosure, each of the
individual embodiments described and illustrated herein has discrete components and features
which may be readily separated from or combined with the features of any of the other
several embodiments without departing from the scope or spirit of the present disclosure.
Any recited method may be carried out in the order of events recited or in any other order that
is logically possible.
Embodiments of the present disclosure will employ, unless otherwise indicated,
techniques of organic chemistry, biochemistry, microbiology, molecular biology,
pharmacology, medicine, and the like, which are within the skill of the art. Such techniques
are explained fully in the literature.
Prior to describing the various embodiments, the following definitions are provided
and should be used unless otherwise indicated.
Unless otherwise defined, all technical and scientific terms used herein have the same
meaning as commonly understood by one of ordinary skill in the art of microbiology,
molecular biology, medicinal chemistry, and/or organic chemistry. Although methods and
materials similar or equivalent to those described herein can be used in the practice or testing
of the present disclosure, suitable methods and materials are described herein.
As used in the specification and the appended claims, the singular forms "a," "an,"
and "the" may include plural referents unless the context clearly dictates otherwise. Thus, for
example, reference to "a support" includes a plurality of supports. In this specification and in
the claims that follow, reference will be made to a number of terms that shall be defined to
have the following meanings unless a contrary intention is apparent.
Discussion :
Embodiments of the present disclosure provide for structures including a conformal
conductive scaffold, methods of making the structure, method of using structure, and the like.
Embodiments of the present disclosure can be used to align cells (e.g., fibroblasts and human
mesenchymal stem cells) on the surface of the conformal conductive scaffold. In a particular
embodiment, cells can be cultured on the surface of the conformal conductive scaffold in an
appropriate medium for the particular type of cell and then a current (e.g., DC) is applied to
the conformal conductive scaffold so that the cells align on the surface of the conformal
conductive scaffold, where the electrical stimulation can be periodically applied to the
electroactive scaffold.
In this regard, embodiments of the disclosure provide for a structure that includes the
conformal conductive scaffold that can be used to align cells. An embodiment of the present
disclosure includes introducing cells to the conformal conductive scaffold, where the
conformal conductive scaffold and the cells are cultured in an appropriate medium.
Subsequently, electrical stimulation can be periodically applied to the cells to cause the cells
to align on the conformal conductive scaffold. In particular, the cells may align along the
backbone of the polymer. In an embodiment, the cells align along the direction of the dip
coating used to dispose the polymer film on the structure. As shown in Example 1, electrical
stimulation of the conformal conductive scaffold in the presence of cells shows alignment of
the cells, which is a characteristic of some cells types including bone cells, cardiac cells, and
nerve cells.
The term "conformal" as used herein refers to materials that are typically three
dimensional and may or may not be inherently conductive.
In an embodiment, the structure includes the conformal conductive scaffold that has a
polyelectrolyte complex, chitosan, and gelatin film, where the chitosan and the gelatin film
can crosslink with genipin. In an embodiment, the polyelectrolyte complex is selected from
the group consisting of: PEDOT derivative, polypyrrole-polystyrenesulfonate (PSS),
polyaniline-PSS, polythiophene-PSS, and a combination thereof. The polymer film can be
coated on the structure using various techniques, including dip coating, drop coating, and spin
coating. In an embodiment, the film can have a thickness of about 1 nm to 1 cm and area of
about 10 mm2 to 10 m2.
To illustrate the interaction of the components, the following is an example of the
interaction. In an embodiment where the polyelectrolyte complex is a PEDOT derivative
(e.g., PEDOT-polystyrenesulfonate (PSS)), the negatively charged sulfates on PEDOT-PSS,
(or those on PEDOT-S, shown below), will non-covalently interact with the positively
charged moieties on chitosan or gelatin (e.g., amines), while genipin will covalently crosslink
with chitosan and gelatin.
In an embodiment, the PEDOT derivative can include a sulfonated PEDOT having the
following structure: ∞ - (wherein n is 1 to infinity (e.g., 10,000, 100,000,
1,000,000, or more)) or the PEDOT derivative can be PEDOT-polystyrenesulfonate (PSS)
(PEDOT-PSS) (where the unit of each be 1 to infinity (e.g., 10,000,
100,000, 1,000,000, or more)). PEDOT-PSS is a mixture of two ionomers that form a
macromolecular salt. In other embodiments, another negatively charged conducting polymer
can be used such as polypyrrole-PSS, polyaniline-PSS, or polythiophene-PSS.
Geni in is a chemical a gardena fluid extract. Genipin has the following structure:
Chitosan is an oligosaccharide including β-linked D-glucosamine and N-actyl-D-
glucosamine that are randomly distributed in the oligomer. In an embodiment, the chitosan
has a molecular weight of about 1 kDa to 20 MDa.
Gelatin is an irreversibly hydrolyzed form of collagen, where the hydrolysis results in
the reduction of protein fibrils into smaller peptides, which will have broad molecular weight
ranges (e.g., about 1 kDa to 20 MDa) associated with physical and chemical methods of
denaturation, based on the process of hydrolysis.
In an embodiment, the cells can be human mesenchymal stem cells, human dermal
fibroblasts, myoblasts, osteoblasts, osteoclasts, neurons, Schwann cells, pluripotent stem
cells, or the like. In an embodiment where the cells are human dermal fibroblast, the medium
can be HDF growth medium, composed of: high glucose Dulbecco's Modified Eagle Medium
(DMEM, 440 mL); fetal bovine serum (50 mL); antibiotic-antimycotic (5 mL); non-essential
amino acids (5 mL), and 2 ng mL- 1 basic fibroblast growth factor.
Electrical stimulation can include direct contact of the material with a power source
via a wire, wireless energy transfer, magnetic force, and the like. In an embodiment, the
electrical stimulation can be direct current (DC) or alternating current (AC). The term
"periodically" refers to applying the electrical stimulation at established time frames that may
be at regular or irregular time intervals on the time frames of seconds, hours, days, weeks, or
months (e.g., about 1 s to 2 months, about 1 hour to 1 day, about 1 day to 1 month, or other
the like) depending upon the specific circumstances. In an embodiment, the impulses of the
electrical stimulation can last on the time frame of seconds, hours, or days (e.g., about 1
second to 1 day, about 10 seconds to 1 hour, about 1 minute to 12 hours, about 1 hour to 1
day, or the like) depending upon the specific circumstances. In an embodiment, the electrical
stimulation may only include a single long pulse that may last seconds to minutes, to hours,
to days. In an embodiment, the electrical stimulation can be in the range of millivolts to volts
(e.g., about 10 mV to 10 volts, about 1 mV to 100 mV, or the like). The time frame, duration
of electrical stimulation, and intensity of the electrical stimulation can be designed based on
particular circumstances and requirements of a specific situation.
As stated above, embodiments of the present disclosure provide for a structure having
the conformal conductive scaffold. In an embodiment, the conformal conductive scaffold can
include one or more agents (e.g., a chemical or biological agent), where the agent can be
disposed indirectly or directly on the conformal conductive scaffold. As described herein, the
agent can include a stem cell such as a human mesenchymal stem cell or human dermal
fibroblast.
In addition, an additional agent that can be disposed on the conformal conductive
scaffold can include, but is not limited to, a drug, a therapeutic agent, a radiological agent, a
small molecule drug, a biological agent (e.g., polypeptides (e.g., proteins such as, but not
limited to, antibodies (monoclonal or polyclonal)), antigens, nucleic acids (both monomelic
and oligomeric), polysaccharides, haptens, sugars, fatty acids, steroids, purines, pyrimidines,
ligands, and aptamers) and combinations thereof, that can be used to image, detect, study,
monitor, evaluate, and the like, the cells. In an embodiment, the agent is included in an
effective amount to accomplish its purpose, where such factors to accomplish the purpose are
well known in the medical arts.
In general, the agent can be bound to the structure by a physical, biological,
biochemical, and/or chemical association directly or indirectly by a suitable means. The term
"bound" can include, but is not limited to, chemically bonded (e.g., covalently or ionically),
biologically bonded, biochemically bonded, and/or otherwise associated with the
electroactive supramolecular polymeric assembly. In an embodiment, being bound can
include, but is not limited to, a covalent bond, a non-covalent bond, an ionic bond, a chelated
bond, as well as being bound through interactions such as, but not limited to, hydrophobic
interactions, hydrophilic interactions, charge-charge interactions, pi-pi stacking interactions,
combinations thereof, and like interactions. In an embodiment, cell-electroactive scaffold
interactions could be controlled through the inclusion of cell-adhesive peptides (e.g., RGD,
YIGSR, KQAGDV, KHIFSDDSSE, KRSR), protease-labile domains (e.g., APGL, VRN, or
indeed oligoalanines that are degraded by elastase), osteoinduction can be enhanced (e.g.,
NSPVNSKIPKACCVPTELSAI), and directing mineralization (e.g. FHRRIKA).
While embodiments of the present disclosure are described in connection with the
Examples and the corresponding text and figures, there is no intent to limit the disclosure to
the embodiments in these descriptions. On the contrary, the intent is to cover all alternatives,
modifications, and equivalents included within the spirit and scope of embodiments of the
present disclosure.
EXAMPLE 1 :
We report the preparation of conducting polymer-based films. Composite biomaterials
based on poly(3,4-ethylenedioxythiophene) derivatives, chitosan and gelatin were prepared
and their physicochemical properties were characterized. Fibroblasts adhered to and
proliferated on the films, and were shown to align with a DC current passed through the
films.
The specific properties of bodily tissues act as cues (individually or in concert) that
determine the behaviour of cells that inhabit them, and are utilised to engineer instructional
tissue scaffolds to facilitate the regeneration of functional tissues.[l] The topographical
properties of tissues may instruct cells to align, as is clearly observable within the
anisotropically aligned pores observed in bone, cardiac, nerve and other tissues [2]. Scientists
and engineers have reported novel methodologies of imparting biomimetic porous structures
within biomaterials, including the removal of sacrificial templates embedded within a matrix
(e.g., colloidal crystals, ice crystals, electrospun fibers), and 3D printing technologies that
offer methods of precisely positioning pores with specific geometries in such structures. [2]
Endogenous electric fields are another cue influencing cell behaviour (e.g. processes
such as embryogenesis and wound healing). Electrical fields are also known to align cells,
with endogenous electric fields playing a role in the alignment of cells,[3] and exogenous
electric fields have been shown to align a variety of cell types (including astrocytes, epithelial
cells, fibroblasts) in vitro,[3] motivating the development of electrically conductive materials
that instruct cell alignment aided by application of an electrical field/current that mimics
endogenous electrical fields/currents.[3]
Conducting biomaterials based on conducting polymers (CPs) such as derivatives of
polyaniline, polypyrrole or polythiophene, have potential for both long term biomedical
applications (e.g. electrodes) and short term biomedical applications (e.g. drug delivery or
tissue engineering). [4] CP-based scaffolds have been developed for the regeneration of bone
and nerve tissues, and organs including the heart and skin. [4]
Layer-by-layer assembly is a method of producing thin multilayer films that was
popularized by Mohwald and others. [5] Conductive multilayer films have been prepared from
a variety of organic electronic components, often for applications in energy, of which a
number of examples based on CPs exist. [5] Wallace and coworkers reported the preparation
of bioerodible CP-based multilayer films based on an anionic sulfonate-displaying
polythiophene derivative (with a w = 13160 Da and = 6682 Da as determined by GPC)
and cationic polyethyleneimine (17 kDa),[6] both of which are below the renal filtration limit
of approximately 50 kDa; and the films were shown to be suitable for the growth and
proliferation of cells derived from the connective and muscle tissue of mice (L929 and
C2C12 cells, respectively). [6] They subsequently showed that it was possible to prepare CP-
based multilayer films based solely on anionic and cationic polythiophene derivatives that
could be -disassembled upon the application of an electrochemical trigger (a potential step of
650 mV for 19-42 hours). [7] Wei and coworkers reported the first example of biologically
functional biodegradable CP-based multilayer films for bone tissue engineering, that were
used for the electrical stimulation of osteoblast precursor MC3T3-E1 cells (derived from
mice) that resulted in increased expression of osteopontin and runt-related transcription factor
2 which are markers of osteogenesis. [8]
Here we describe the preparation of CP-based films composed of poly(3,4-
ethylenedioxythiophene) (PEDOT) derivatives, chitosan and gelatin, that are crosslinked by
genipin (Figure 1.1). These conducting films enabled the electrical stimulation of human
dermal fibroblasts cultured thereon which resulted in the preferential alignment of the cells
with a DC current passed through the films.
Films were deposited on non-conductive glass slides that were previously rendered
positively charged by modification with aminopropyltrimethoxysilane. The polyelectrolyte
complex composed of PEDOT and polystyrenesulfonate (PSS), PEDOT-PSS, or the
sulfonated PEDOT derivative PEDOT-S (Figure 1.1) were used for film preparation because
they are electrochemically stable over periods long enough to facilitate short term electrical
stimulation of tissues in their vicinity, and have been shown to be relatively non-
immunogenic after implantation in various tissues. The polysaccharide chitosan was chosen
as the cationic polymer to interact with the anionic PEDOTs (PEDOT-PSS and PEDOT-S,
respectively) as it is also known to be relatively non-immunogenic (particularly by
comparison with polyethyleneimine) and promotes cell adhesion. Furthermore,
electrochemically reducing the backbone of PEDOT-S makes it less positively charged which
in turn reduces the number of sulfonates necessary to dope the polymer backbone rendering
the surface charge of PEDOT-S films to be predominantly negative; therefore, PEDOT-S can
be employed as a surface coating that enables electrochemically triggered cell desorption.
Therefore we employed gelatin as a surface coating to render the films cell adhesive, and
crosslinked the films with genipin (a natural crosslinker of biopolymers including chitosan,
collagen and gelatin, which is markedly less toxic than the more commonly used
glutaraldehyde), to ensure film stability for the duration of the experiments.
Film preparation by drop casting yielded films with µιη-scale roughnesses, water
contact angles (WCAs) of approximately 50°, and conductivities of the order of 10 7 S cm 1
(Table 1). By contrast, layer-by-layer assembly via dip-coating (Figure 1.4) yielded
multilayer films that were smoother (nm-scale roughnesses) and more conductive, 10 4 to 10 3
S cm 1 (Table 1). Film conductivities are on a similar order of magnitude to those of
mammalian tissues (typically > 10 4 S cm 1) .[9]
Table 1. Surface properties of the films.
Ra) average roughness. Rq) root-mean-square roughness. Error bars represent
standard deviations (the two highlighted numbers were different than in the provisional,
please confirm this are correct)
With a view to the application of the multilayer films as coatings for biomaterials we
cultured human dermal fibroblasts (FIDFs) on their surfaces and compared them to
commercially available tissue-culture treated Corning® Costar® tissue culture plate (TCP)
controls. HDFs cultured on TCP controls adhered to and spread on the TCP as expected
(Figure 1.2A), FIDFs had somewhat more rounded morphologies when cultured on the
PEDOT-PSS-based or PEDOT-S-based multilayer films (Figure 1.2B and 1.2C) which is
indicative of slightly poorer cell adhesion to the conducting substrates despite the gelatin
coating. Interestingly, we found that cell viability for the HDFs cultured on the PEDOT-
based films was comparable, and indeed somewhat better than for HDFs cultured on TCP
controls (Figure 1.2D). We found that HDFs adhered to and proliferated on the surface of the
films over the period of 4 days, although HDFs cultured on the TCP control substrates
proliferated somewhat faster than on the PEDOT-PSS-based or PEDOT-S-based films
(Figure 1.2E), similar to the findings of Wallace and coworkers with mouse derived L929 and
C2C12 cells on polythiophene-based films. [6]
To assess the potential of the PEDOT-based films to act as instructive coatings for
biomaterials, we investigated four different systems: 1) cells seeded on PEDOT-PSS-based
multilayer films without electrical stimulation, 2) cells seeded on PEDOT-PSS-based
multilayer films with electrical stimulation, 3) cells seeded on PEDOT-S-based multilayer
films without electrical stimulation, and 4) cells seeded on PEDOT-S-based multilayer films
with electrical stimulation using a custom built setup (Figure 1.5). Those samples without
electrical stimulation were cultured for 3 days, whereas those that were electrically stimulated
were cultured for 1 day without stimulation, followed by one period of stimulation at 10 mV
mm 1 for 4 hours, then 44 hours without stimulation.
We found that both the PEDOT-PSS-based and PEDOT-S-based substrates were
stable to electrical stimulation at 10 mV mm 1 for 4 hours, and moreover that HDFs
maintained adherence to the substrates after electrical stimulation. We observed that HDFs
displayed a moderate preference for aligning with the direction in which the slides were
dipped during the dip coating process (Figures 1.3A-E). Cells without any preferential
alignment would be expected to have an average orientation of 45° (Figures 1.3A-F, 1.6 and
1.7A-B), however, we saw that HDFs on PEDOT-PSS-based multilayer films had an average
orientation of 38.6° ± 1.5° (Figures 1.3A and 1.3E), whereas HDFs on PEDOT-S-based
multilayer films had an average orientation of 35.3° ± 1.8° (Figure 1.3B and 1.3E), which is
likely to be because the polymer chains were aligned during the dip coating process as is
commonly observed for multilayer films prepared in this fashion. Interestingly, electrical
stimulation of HDFs on the conductive substrates led to an increase in their propensity to
align with the direction of the DC current passed through the substrate, and we found that
HDFs on PEDOT-PSS-based multilayer films had an average orientation of 27.7° ± 1.7°
(Figures 1.3C and 1.3E), whereas FIDFs on PEDOT-S-based multilayer films had an average
orientation of 32. 1° ± 1.1° (Figures 1.3C and 1.3E). The fact that the increase in cell
alignment was somewhat lower for the cells on the PEDOT-S-based multilayer films than the
PEDOT-PSS-based multilayer films is probably because of minor changes in the surface
chemistry of the films that alter cell-substrate interactions as reported by Berggren and
coworkers for PEDOT-S-based films. Further evidence in support of this hypothesis can be
found in changes in the length of the cells on the PEDOT-S-based films after electrical
stimulation, with their average lengths reduced from approximately 135 µ to 80 µ
(Figures 1.3C, 1.3D, 1.3F, 1.6 and 1.7A-B). Nevertheless, the increased cell alignment on
both PEDOT-PSS-based and PEDOT-S-based multilayer films suggests that they may find
application as instructive biomaterial coatings, potentially for tissue engineering of skin or a
variety of other niches in which cell alignment is an important feature. [2]
Cell alignment within specific tissues is clearly observable within the anisotropically
aligned pores observed in bone, cardiac, nerve and other tissues. This has motivated the
development of novel materials that instruct the cells thereon/therein to align, most
commonly through topological cues engineered into the materials.
In this example we report the preparation of CP-based multilayer films. Films based
on poly(3,4-ethylenedioxythiophene) derivatives, chitosan and gelatin were prepared by dip
coating and their physicochemical properties characterized. Fibroblasts cultured on their
surfaces of such films were shown to adhere and proliferate in vitro, and moreover, to
respond to a DC current passed through the films by aligning with the current. Such
conductive films have prospects for the development of thin conformal bioactive coatings
that induce cell alignment upon the surface of implantable biomaterials. Furthermore, the fact
that human mesenchymal stem cells adhere to the films (Figure 1.8A-B) highlights their
potential for patient specific applications as personalized medical devices.
Manufacturing multilayer films by dip coating is very attractive as it is simple and
industrially scalable. Moreover, the properties of the films could be easily tuned by altering
the contents of the dipping baths. For example, using water soluble CPs with molecular
weights below the renal filtration limit of approximately 50 kDa allows the preparation of
bioerodible conductive films, and it is likely that adhesion could be improved by coating with
mixtures of extracellular matrix-derived proteins (e.g. collagen, fibronectin, laminin). We
believe the simplicity of our approach enables us to tailor the properties of the films to
specific niche applications (and potentially specific patients).
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Example 1 Experimental Details
Materials and methods
Unless otherwise stated, all chemicals were of ACS grade, purchased from Sigma-
Aldrich and used as received without further purification, e.g., Poly(3,4-
ethylenedioxythiophene)-poly(styrenesulfonate) 1.1% in H20 , neutral pH, high-conductivity
grade (PEDOT-PSS), chitosan (70 kDa), phosphate buffered saline (PBS) tablets etc.
Hydroxymethyl EDOT was purchased from Sarchem Laboratories, Inc., and ITO slides were
purchased from Ted Pella, Inc. For cell culture experiments, all reagents were purchased from
Invitrogen (Carlsbad, CA) unless otherwise stated. Human dermal fibroblasts (hDFs) were
purchased from Lonza (Gaithersburg, MD).
Film Preparation:
Aminopropyltrimethoxysilane-functionalized glass microscope slides were used as
positively charged substrates for the deposition of conducting polymer-based films.
Negatively charged polymers were either poly(3,4-ethylenedioxythiophene)-
poly(styrenesulfonate) 1.1% in H2O, neutral pH, high-conductivity grade (PEDOT-PSS), or
PEDOT-S; whereas the positively charged polymer was chitosan (70 kDa) that was dissolved
in aqueous acetic acid ( 1 % v/v).
Drop cast films were prepared by briefly vortexing aqueous solutions of the polymers
(typically 1 mg mL , adjusted to pH 7 and buffered with 10 mmol PBS), casting on glass
slides, air drying for 24 hours and then drying under vacuum for 48 hours.
Multilayer films were prepared from aqueous solutions of the polymers (typically 1
mg mL 1, adjusted to pH 7 and buffered with 10 mmol PBS) using a Gilson 223 Sample
Changer (Gilson, Inc. Middleton, WI, USA) converted for use as a dip coater controlled by a
script written in LabVIEW (National Instruments, Inc., Austin, TX, USA). Films were
deposited by repetitive sequences of: dipping in negatively charged polymer solution (dip
time 15 minutes), air drying 1 minute, rinsing in water (dip time 30 seconds), air drying 1
minute, dipping in chitosan (70 kDa, dip time 15 minutes), air drying 1 minute, rinsing in
water (dip time 30 seconds), air drying 1 minute. The films were air dried for 24 hours and
then dipped in a solution of gelatin ( 1 mg/mL, dip time 15 min), air dried for 1 minute, rinsed
in water (dip time 30 seconds), air dried 1 minute, rinsed in water (dip time 30 seconds), air
dried for 24 hours and vacuum dried for 48 hours.
Profilometry:
Profilometry was carried out using a Veeco Dektak 6M Stylus Profilometer (Veeco
Instruments Inc., NY) fitted with a 12.5 µ stylus tip. The profilometer was isolated on an air
table to reduce ambient vibrations. The profilometer was operated at 10 mg of stylus force,
and used to record profiles of distances of ca. 1 cm, recording data points every 555 nm. Data
analysis was carried out with the software provided by the manufacturer, which allowed the
determination of the thickness and roughness of the films. The surface roughness parameters
are analyzed and reported in accordance with the ISO 25178 series. The average roughness
(Ra) is the arithmetic average of the deviation from the mean line, and is the most used
international parameter of roughness, and the root-mean-square roughness (Rq) is based upon
this.
Water contact angle measurements:
Measurements were carried out with a high-speed contact angle measurement device
(FTA200 video-based semi-automatic contact angle goniometer supplied by First Ten
Angstroms, Inc., Portsmouth, VA, USA). Images of a drop of deionized water (2 µ ) laid on
the surface of the samples were recorded at a frame rate of 360 frames per second, and the
contact angles for the droplets were recorded after 3 seconds of contact with the film. The
reported values are the average of at least 3 measurements at different positions on a film.
Conductivity Determination:
Resistance (R in Ω) was measured between two silver electrodes using a digital
multimeter (DM-8A, Sperry Instrument, Milwaulkee, WI). The resistivity, p (Ω/cm), of the
films was determined in accordance with equation 1:
p =Rwt/L (1)
The resistance, R, was recorded in at least ten different positions on the materials, Wis the
width of the film, t corresponds to the thickness of the film (as determined via profilometry),
and L is the distance between the two silver electrodes. The conductivity (S/cm) of the films
was determined in accordance with equation 2 :
σ = 1/p (2)
In Vitro Cell Culture Studies
Sample preparation and conditions for in vitro cell culture:
Pristine indium tin oxide (ITO) slides (Ted Pella, Inc.) or glass slides coated with
electroactive multilayer films (of ca. 1 cm2) were inserted in tissue culture plates and
sterilized by incubation in 70 % ethanol solution, followed by exposure to UV for 30
minutes. After sterilization, films were incubated for 30 minutes under 3 mm of HDF growth
medium composed of: high glucose Dulbecco's Modified Eagle Medium (DMEM, 440 mL);
fetal bovine serum (50 mL); antibiotic-antimycotic (5 mL); non-essential amino acids (5
mL), and 2 ng mL- 1 basic fibroblast growth factor. Medium was aspirated and replaced prior
to HDF seeding. Cell viability before starting the experiment was determined by the Trypan
Blue (Sigma, USA) exclusion method, and the measured viability exceeded 95 % in all cases.
Cells were seeded at 5,000 cells per cm2 under 3 mm of medium, and incubated at 37 °C,
95% humidity, and a C0 2 content of 5%.
Cell proliferation studies:
After 2 days the cells were washed gently with PBS, followed by the addition of fresh
medium containing 10% v/v of the AlamarBlue® reagent. After 2.5 hours of culture, the
medium was aspirated and replaced with fresh medium, and 100 µΐ of the aspirated medium
containing the AlamarBlue® reagent was placed in a 96 well plate, and the fluorescence was
measured with a fluorimeter (Synergy HT Multi-Mode Microplate Reader, Biotek US,
Winooski, VT). Two controls were considered during the measurement of the fluorescence:
the first was wells containing medium alone (i.e. no cells or AlamarBlue® reagent), which
was not fluorescent; and the second was wells that contained the AlamarBlue® reagent but
no cells (used for baseline correction). Numbers of cell adhered to the various surfaces
studied herein are reported relative to their initial seeding density of 5,000 cells per cm2,
which was assigned an arbitrary value of 100%. After another 2 days (i.e. at 4 days after
initial seeding) this process was repeated. The medium was aspirated and replaced once more
at 6 days after initial seeding, and finally after a total of 8 days in culture the viability of the
cells was evaluated using a LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells
(Molecular Probes, Eugene, OR). The medium was removed and cells on the surfaces were
incubated with 4 µΜ ethidium and 2 µΜ calcein AM in PBS for 15 min at 37 °C in the dark.
Live cells were stained green because of the cytoplasmic esterase activity, which results in
reduction of calcein AM into fluorescent calcein, and dead cells were stained red by
ethidium, which enters the cells via damaged cell membranes and becomes integrated into the
DNA strands. Fluorescence images of cells were captured using a color CCD camera
(Optronics® MagnaFire, Goleta, CA, USA) attached to a fluorescence microscope (ΓΧ -70;
Olympus America Inc.). Cells were counted with the cell counter tool (plugin) in the open
source program ImageJ, all cells on all images were counted. Results of AlamarBlue® assays
presented are the average of four samples and ethidium/calcein stained images are
representative of 3 samples (typically 3 images per sample).
Cell orientation studies in the absence or presence of electrical stimulation:
Cell orientation studies employed a custom built setup (see Figure 1.6). Electroactive
multilayer films supported on glass slides were (width of 2.5 cm, length of 7.5 cm) were
sterilized by incubation in 70 % ethanol solution, followed by exposure to UV for 30
minutes. Polycarbonate wells (square polycarbonate blocks, thickness of 1 cm, sides of 2.5
cm, with square holes with sides of 0.9 cm cut out), Dow Corning® high vacuum grease, and
medium binder clips (Staples®, Framingham, MA) were sterilized by autoclaving. Holes were
drilled into the sides of 10 cm polystyrene Petri dishes using a Dremel saw (Lowes,
Mooresfield, NC, USA), and the plates were sterilized by exposure to UV for 60 min.
Adhesive-backed copper tape (5 mm width, Ted Pella, Inc.), waterproof Kapton ® tape ( 1 cm
width, Fisher Scientific, Waltham, MA, USA), wires and alligator clips were sterilized by
exposure to UV for 60 min.
Electroactive multilayer films supported on glass slides and secured in position with
two thin strips of adhesive-backed copper tape that were attached to the films, parallel to one
another and separated by a distance of ca. 4 cm. One face of the polycarbonate wells was
coated with vacuum grease and placed on the electroactive tissue scaffolds, greased side
down, in contact with the glass slide. A binder clip on either side of the well was used to
secure this in position and render it water tight. A strip of copper tape was run between the
parallel copper strips attached to the scaffolds and the ends of the slides as points of contact
for the alligator clip-terminated wires attached to the multipotentiostat (CH Instruments,
Austin, TX, USA). The counter and reference electrodes were connected together and clipped
to copper tape on one side of the slide, and the working electrode was clipped to copper tape
on the other side of the slide. HDFs were plated and cultured for 1 day as described above. A
potential step of +10 mV mm 1 was placed across the substrate for the duration of 4 hours,
after which the wires were disconnected and the substrates cultured as normal for a further 40
hours. The medium was aspirated and the samples were washed gently with PBS. Cells were
fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.1% Triton X-100
(Fluka) and 2% bovine serum albumin (BSA) in PBS buffer for 5 min, followed by blocking
with 2% BSA in PBS buffer for 30 min at room temperature. Actin filaments and cell nuclei
within cells were stained with Alexa Fluor 488® Phalloidin (Life Technologies, USA) for 30
min and 4',6-diamidino-2-phenylindole (DAPI, Invitrogen, USA) for 5 min. The cells were
then washed three times with PBS buffer and stored at 4 °C until images were acquired.
Fluorescence images of cells were captured using a colour CCD camera (Optronics®
MagnaFire, Goleta, CA, USA) attached to a fluorescence microscope (ΓΧ -70; Olympus
America Inc.). Images are representative of 3 samples. Images were analysed using ImageJ.
A line was drawn across cells for measurements, and lengths in pixels were converted to
lengths in µιη using the measure bar in ImageJ. Angles were determined measuring from the
left side of the image to the right side of the image to ensure that all angles measured would
be within the 1st and 2nd quadrants. In Excel the absolute value of the negative angles were
taken so all angles measured would be converted to the 1st quadrant, and these data were
converted to cartesian coordinates. Polar plots were generated automatically using a polar
plot add-in (http://www.andypope.info/charts/polarplot.htm) and the data transferred to Excel
for further calculations. A minimum of 150 cells were counted per experiment, and error bars
represent standard errors.
Human Mesenchymal Stem Cell Adhesion Studies:
HMSCs were supplied by Lonza (Walkersville, MD). Samples were prepared as
described above (in "film preparation"). After sterilization, the samples were incubated for 30
minutes in 24 well plates containing HMSC growth medium that was composed of: high
glucose Dulbecco's Modified Eagle Medium (DMEM, 440 mL); fetal bovine serum (50 mL);
antibiotic-antimycotic (5 mL); non-essential amino acids (5 mL), and 2 ng mL-1 basic
fibroblast growth factor. Medium was aspirated and replaced prior to HMSC seeding. Cell
viability before starting the experiment was determined by the Trypan Blue exclusion
method, and the measured viability exceeded 95 % in all cases. HMSCs were seeded at 5,000
cells cm-2, and incubated at 37 °C, 95 % humidity, and a C02 content of 5 % . Samples were
fixed and stained as described above (n = 3).
It should be noted that ratios, concentrations, amounts, and other numerical data may
be expressed herein in a range format. It is to be understood that such a range format is used
for convenience and brevity, and thus, should be interpreted in a flexible manner to include
not only the numerical values explicitly recited as the limits of the range, but also to include
all the individual numerical values or sub-ranges encompassed within that range as if each
numerical value and sub-range is explicitly recited. To illustrate, a concentration range of
"about 0 .1% to about 5%" should be interpreted to include not only the explicitly recited
concentration of about 0.1 wt% to about 5 wt%, but also include individual concentrations
(e.g., 1%, 2%, 3%, and 4%) and the sub-ranges (e.g., 0.5%, 1.1%, 2.2%, 3.3%, and 4.4%)
within the indicated range. In an embodiment, the term "about" can include traditional
rounding according to significant figures of the numerical value. In addition, the phrase
"about 'x' to 'y' " includes "about ' ' to about 'y"\
Many variations and modifications may be made to the above-described
embodiments. All such modifications and variations are intended to be included herein
within the scope of this disclosure and protected by the following claims.
CLAIMS
We claim:
1 . A structure, comprising:
a conformal conductive scaffold including a polyelectrolyte complex, chitosan, and
gelatin, which are crosslinked by genipin.
2 . The structure of claim 1, wherein the polyelectrolyte complex is selected from the
group consisting of: PEDOT derivative, polypyrrole-polystyrenesulfonate (PSS), polyaniline-
PSS, polythiophene-PSS, and a combination thereof.
3 . The structure of claim 2, wherein the PEDOT derivative is a sulfonated PEDOT
having the following structure: - ¾ o the PEDOT derivative is PEDOT-
polystyrenesulfonate (PSS) (PEDOT-PSS).
4 . The structure of claims 1, 2 or 3, wherein the conformal conductive scaffold is a
polymer film.
5 . The structure of claim 4, wherein the polymer film is a multi-layer film assembled by
dip-coating.
6 . The structure of claim 5, wherein the multi-layer film has a conductivity similar to
that of mammalian tissues.
7 . The structure of claim 6, wherein the conductivity is about 10 4 S cm 1 to 10 3 S cm 1 .
8 . A method of alignment of cells, comprising:
providing a structure having a conformal conductive scaffold including a
polyelectrolyte complex, chitosan, and gelatin, which are crosslinked by genipin;
introducing cells to the structure;
periodically providing electrical stimulation to cells; and
aligning the cells on the structure.
9 . The method of claim 8, wherein the cell is a human dermal fibroblast or a human
mesenchymal stem cell.
10. The method of claim 8 or 9, wherein the electrical stimulation is direct current (DC).
11. The method of claim 8 or 9, wherein the electrical stimulation is alternating current
(AC).
12. The method of claim 8, wherein the alignment is in line with the dip-coating direction.
13. The method of claim 8, wherein the polyelectrolyte complex is selected from the
group consisting of: PEDOT derivative, polypyrrole-polystyrenesulfonate (PSS), polyaniline-
PSS, polythiophene-PSS, and a combination thereof.
14. The method of claim 13, wherein the PEDOT derivative is a sulfonated PEDOT
having the following structure: - 0 r the PEDOT derivative is PEDOT-
polystyrenesulfonate (PSS) (PEDOT-PSS).
15. The method of claim 8, wherein the conformal conductive scaffold is a polymer film.
16. The method of claim 15, wherein the polymer film is a multi-layer film assembled by
dip-coating.
17. The method of claim 16, wherein the multi-layer film has a conductivity similar to
that of mammalian tissues.
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